pattypellikka Profile Banner
Dr.Patricia Pellikka Profile
Dr.Patricia Pellikka

@pattypellikka

Followers
5K
Following
4K
Media
125
Statuses
984

President Mayo Clinic O&C. Cardiologist. Editor of JASE & scientist - echo, valves, CAD, HF, AI. Past president of ASE; mom; likes 📚 🎼 🎶 & fast 🚘

Rochester, MN
Joined August 2013
Don't wanna be here? Send us removal request.
@pattypellikka
Dr.Patricia Pellikka
4 years
I’m thrilled and honored to fulfill this commitment to @ASE360 and our profession!.
@JournalASEcho
JASE
4 years
Congratulations to @pattypellikka the new Editor in Chief of @JournalASEcho Just announced at @ASE360 BOD meeting
Tweet media one
40
22
192
@pattypellikka
Dr.Patricia Pellikka
4 days
Important paper @JournalASEcho.
@DocStrom
Jordan Strom, MD, MSc, FACC, FASE
4 days
New @ASE360 Diastology guidelines now published (. New algorithm below, now with LARS and IVRT. Also new recs for OHT, MAC, and AF patients. Congrats @SNagueh @dysanborn and coauthors @JaeKOh2 @BonitaEcho @KristenBillick @AllanLKleinMD1 et al.
Tweet media one
0
9
27
@pattypellikka
Dr.Patricia Pellikka
9 days
RT @ASE360: UPCOMING WEBINAR: On July 15, join us for the #ASEWebinar, "AI Meets Echocardiography: Where We Are Now and What's Next!". Sign….
0
16
0
@pattypellikka
Dr.Patricia Pellikka
2 months
In commemoration of 100 years of continuous publication of @MayoProceedings my commentary describes 50 years of progress #EchoFirst @AJamilTajik @MayoClinicCV Mayo Clinic Proceedings and the Development of Echocardiography
0
5
27
@pattypellikka
Dr.Patricia Pellikka
3 months
RT @PWesslyMD: 👀 Both patients with severe AR have nearly identical linear dimensions. But their volumes tell a different story:.🫀 EDV: 2….
0
7
0
@pattypellikka
Dr.Patricia Pellikka
3 months
RT @NadeenFaza: #ASEchoJC.How would you evaluate AR severity in eccentric jets🤔? .Join our #ASEchoJC on Wed 4/23 at 8-9 PM ET as we dive in….
0
7
0
@pattypellikka
Dr.Patricia Pellikka
3 months
Our FDA-approved AI echo model to detect HFpEF from an apical 4-ch videoclip also works with handheld US! @ultromics @MayoClinicCV @JournalASEcho Application of an Artificial Intelligence Model to Detect Heart Failur.
0
16
44
@pattypellikka
Dr.Patricia Pellikka
3 months
Join us at Echo in the Nation's Capital, Oct 10-12, for the latest practical review on echo. 3D, new diastolic function GL, interventional echo, AI, stress, valves, cardiomyopathy, strain, & fun. @MayoClinicCV @iamritu @MDMankad
0
7
17
@pattypellikka
Dr.Patricia Pellikka
3 months
RT @iamritu: atrial functional mitral regurgitation📝.🔺Diastolic dysf, E/e′ ratio & LAVI ≥ 40 mL/m2 assoc w⬆️☠️not EOA.🔺AFMR presence more p….
0
22
0
@pattypellikka
Dr.Patricia Pellikka
3 months
RT @DocStrom: New publication in @NatureComms (, the result of a 2-year collab with @ultromics to compare an #AI mo….
0
18
0
@pattypellikka
Dr.Patricia Pellikka
4 months
RT @JACCJournals: LV dysfunction in AR: time to change the guidelines for AVR timing? In patients with class I/IIA indications for AVR, #ec….
0
47
0
@pattypellikka
Dr.Patricia Pellikka
4 months
Monitor for LVEF<60%, iESV>/=45mL/m2, and GLS worse than -15% for improved survival in asymptomatic severe aortic regurgitation: Is It Time to Change the Guidelines? | JACC: Cardiovascular Imaging
1
8
48
@pattypellikka
Dr.Patricia Pellikka
5 months
Important paper @JournalASEcho.
@KevinHarrismd
Kevin Harris
5 months
Annual growth for ascending aorta is 0.1 mm/year for trileaflet aortic valves, 0.4 mm for bicuspid valves. Not influenced by ao size or AS, this data may inform echo surveillance intervals. #EchoFirst .
Tweet media one
Tweet media two
0
4
10
@pattypellikka
Dr.Patricia Pellikka
5 months
Recent RCTs support a shift in guidelines: AVR for asymptomatic pts with severe AS. Note this commentary with Drs. Lindman and Braunwald. Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis
4
20
70
@pattypellikka
Dr.Patricia Pellikka
5 months
RT @JACCJournals: High-gradient (peak velocity ≥4 m/s, mean gradient ≥40 mmHg) #vhdAS w/ valve area >1.0 cm2 had better survival than other….
0
17
0
@pattypellikka
Dr.Patricia Pellikka
5 months
Prevalence of Cardiac Amyloidosis in Patients Undergoing Echocardiogra. In pts having clinically indicated TTE, cardiac amyloid was present in 1.25%; another 0.5% had possible CA @MayoClinicCV @JonathanKnottMD.
0
9
46
@pattypellikka
Dr.Patricia Pellikka
6 months
RT @EACVIPresident: 📣🗣️The next #EACVI 2025 Congress will be held from 11 to 13 December 2025 in Vienna 🇦🇹. We invite you to share your….
0
40
0
@pattypellikka
Dr.Patricia Pellikka
6 months
I'm looking forward to the latest on echo in valve disease, advances in AI, and @JournalASEcho Board meeting, but especially to reconnecting with friends! ♥️#ASE2025. See you there!.
@iamritu
Ritu Thamman MD
6 months
Register today for #ASE2025 & win prizes like gift cards & celebrate past @ASE360 president @mswami001 birthday today! #ASE50th #SeeYouInNashville #HarmonizingHearts
Tweet media one
1
7
26
@pattypellikka
Dr.Patricia Pellikka
7 months
AI in valve disease- such an exciting topic! Thanks for inviting me program chair & Pres-elect @denisamuraru and Pres @VDelgadoGarcia ❤️! Wonderful program @MayoClinicCV @ultromics.
@iamritu
Ritu Thamman MD
7 months
@pattypellikka ⭐️⭐️⭐️⭐️⭐️ #EuroEcho2024 honorary lecture AI & valvular 🫀dz.DICOM data uses V max for AS not average velocities.Signal data: CXR to .classify #echofirst 2D & 3D data by CNN .Pitfalls: AI can’t exclude post extra systolic beats (afib) AI can
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
12
42
@pattypellikka
Dr.Patricia Pellikka
7 months
RT @rafavidalperez: #EuroEcho2024 @escardio #EACVI Honorary Lecture #Artificialntelligence an opportunity to revolutionise diagnosis of va….
0
4
0